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Abstract
Objective: Little evidence exists concerning the optimal model of inpatient care for
patients with longstanding anorexia nervosa (AN). Self-admission has been developed
as a treatment tool whereby patients with a history of high healthcare utilization are
invited to decide for themselves when brief admission is warranted. The aim of this
study was to evaluate the impact of a self-admission program on healthcare utiliza-
tion, eating disorder morbidity, health-related quality of life (HRQoL), and sick leave
for patients with AN.
Method: In this cohort study, 29 participants with AN in a Swedish self-admission
program were compared to 113 patients with longstanding illness but low previous
utilization of inpatient treatment, matched based on age, illness duration, and body-
mass index (BMI). Data on healthcare utilization, eating disorder morbidity, and sick
leave were obtained from national population and eating disorder quality registers.
Results: Participants displayed a >50% reduction in time spent hospitalized at 12-
month follow-up, compared to nonsignificant changes in the comparison group. A
sensitivity analysis comparing participants to a moderate-utilization comparison sub-
group strengthened this observation. In contrast, the approach did not affect partici-
pants' BMI or eating disorder morbidity. Regarding HRQoL, mixed results were
observed. In terms of sick leave, a beneficial but nonsignificant pattern was seen for
participants.
Discussion: These findings indicate that self-admission is a viable and helpful tool
within a recovery model framework, even though it does not lead to symptom remis-
sion. In its proper context, self-admission could potentially transform healthcare from
crisis-driven to pre-emptive, and promote autonomy for severely ill patients.
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1 | INTRODUCTION
Treatment for anorexia nervosa (AN) can often be successfully adminis-
tered in outpatient settings (Brockmeyer, Friederich, & Schmidt, 2018;
Keel & Brown, 2010). However, in as many as 20–30% of individuals
with AN, the course of illness becomes prolonged and may lead to
enduring disability (Dobrescu et al., 2020; Eddy et al., 2017). This clinical
presentation has come to be referred to as severe and enduring AN (SE-
AN) (Broomfield, Stedal, Touyz, & Rhodes, 2017), but there is little con-
sensus in the literature regarding an exact definition of this condition
(Hay & Touyz, 2018; Wildes et al., 2016; Wonderlich, Bulik, Schmidt,
Steiger, & Hoek, 2020). Some AN patients require lengthy periods of
inpatient treatment and relapse after discharge is common—a scenario
that risks evolving into a “revolving door” pattern (Wonderlich
et al., 2020). Unfortunately, there is still little evidence concerning the
optimal model of inpatient care for patients with longstanding AN
(Wonderlich et al., 2020) and unlike psychiatry in general, the hospitaliza-
tion rate for this group has not been markedly reduced in recent decades
(Papadopoulos, Ekbom, Brandt, & Ekselius, 2009).
Self-admission has been offered in Norway and the Netherlands
for over a decade as a tool in the treatment of longstanding mental ill-
ness such as schizophrenia, bipolar disorder, and borderline personal-
ity disorder (Strand & von Hausswolff-Juhlin, 2015). Similar programs
have been introduced in Sweden (Eckerström et al., 2019; Strand,
Gustafsson, Bulik, & von Hausswolff-Juhlin, 2015; Westling
et al., 2019) and Denmark (Thomsen et al., 2018). The self-admission
model has previously been described in detail in this journal (Strand
et al., 2015; Strand, Bulik, von Hausswolff-Juhlin, & Gustafsson, 2017).
In self-admission, patients who are well known to a service and who
have a history of high utilization of inpatient/residential treatment are
invited to decide for themselves when brief admission—usually 3–
7 days at a time—is warranted. Participants self-admit by contacting
the designated ward directly. They are also free to discharge at will.
Central to the approach is that the patients' reasons for choosing to
self-admit are not questioned. Participants are welcome to admit
themselves because of deteriorating mental health, acute stress, lack
of structure in everyday life, loneliness, or any other reason. Hence,
the traditional inpatient admission model with a clinician serving as
gatekeeper is bypassed.
The rationale behind self-admission includes increasing patient
autonomy and agency, promoting early help-seeking, reinforcing the
asylum function of the inpatient ward, avoiding coercive interven-
tions, and reducing total time spent in inpatient treatment (Strand &
von Hausswolff-Juhlin, 2015). Patients in self-admission programs
usually have a history of multiple and prolonged hospital admissions.
Hopefully, encouraging self-monitoring of their mental health status
and allowing swift help seeking can minimize the lag between first
signs of deterioration and hospital admission, which may in turn
reduce the need for prolonged episodes of inpatient treatment. How-
ever, some concerns have been raised regarding priority setting and
cost-effectiveness in these programs (Strand & Sjöstrand, 2019).
Pilot studies on Norwegian self-admission programs targeting
patients with schizophrenia and bipolar disorder have been promising:
time spent in inpatient treatment was reduced by 22–56% and time
spent in involuntary inpatient treatment by 51–61% across studies
(Hanneborg & Ruud, 2011; Heskestad & Tytlandsvik, 2008; Sollied &
Måsø Helland, 2010; Støvind, Hanneborg, & Ruud, 2012; Tytlandsvik
& Heskestad, 2009). More recent controlled studies in the same
patient groups from Norway (Sigrunarson, Moljord, Steinsbekk,
Eriksen, & Morken, 2016) and Denmark (Thomsen et al., 2018) have,
however, presented a somewhat sobering picture with control groups
subjected to treatment as usual reducing their utilization of inpatient
treatment in equal proportions to or even more than self-admission
participants (Strand & von Hausswolff-Juhlin, 2018). The self-admis-
sion program at the Stockholm Centre for Eating Disorders (SCÄ)
described in the present article is the first to target patients with an
eating disorder.
We have previously presented a qualitative study on participants'
experiences of self-admission in this journal (Strand, Bulik, et al., 2017).
In brief, participants with AN reported a high level of satisfaction with
the program and experienced increased agency and motivation. They
described how self-admission could provide a safety net that led to
strengthened feelings of security in everyday life. However, they also
reported that the model requires a certain level of maturity and an
encouraging environment to overcome barriers such as ambivalence that
could otherwise hinder optimal use. To this date, no study on how self-
admission affects quantifiable outcomes, such as healthcare utilization or
eating disorder morbidity, for patients with AN has been published.
1.1 | Objective
The aim of this study was to evaluate the impact of a self-admission
program on healthcare utilization, eating disorder morbidity, health-
related quality of life (HRQoL), and sick leave for patients with AN.
Our primary hypothesis was that participants in the self-admission
program would reduce their overall time spent in inpatient treatment
compared to a matched comparison group. Secondary hypotheses
were that participation would also favorably affect eating disorder
morbidity, HRQoL, and days on sick leave.
2 | METHOD
2.1 | Setting
The present study was conducted at SCÄ, which is a public sector
specialist service for the treatment of eating disorders in Stockholm,
Sweden, run by the Stockholm County Council. The catchment area is
Metropolitan Stockholm with a population of 2.2 million. Treatment
at the hospital is publicly funded, with only minor patient fees in con-
sonance with all Swedish public healthcare; the per diem patient fee
for inpatient treatment (regular as well as self-admission) is currently
equivalent to 10 United States dollars.
At the adult inpatient ward, two beds out of 11 are reserved for
patients in the self-admission program. Regular admissions to the
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remaining nine beds are initiated by the outpatient units on an elective
basis; these are usually voluntary admissions, although involuntary
commitment according to Swedish law also occurs. Due to the often
prolonged nature of these regular admissions, the patient turnover at
the ward is low and there is typically a several weeks wait for regular
admission. No emergency admissions are available; instead, emergency
cases are routinely handled by general psychiatry or somatic healthcare.
Overall, the inpatient treatment provided at the hospital would proba-
bly best be described as residential care in a United States setting.
To be eligible for the self-admission program, patients must maintain
continuous treatment contact at the adult outpatient or day-treatment
units. They must have had at least one treatment episode in the adult
inpatient ward during the past 3 years, so that they are familiar with the
treatment framework. Exclusion criteria for the program are current sui-
cidal or high-risk self-injurious behavior, the presence of an untreated
substance use disorder, and/or medical instability requiring urgent
somatic inpatient treatment; these are the same exclusion criteria used
for regular inpatients at the ward. No criteria specifically related to
body-mass index (BMI) are applied. Usually, participation in the program
is suggested by a patient's treatment contact at the inpatient ward or
outpatient clinic and an in-depth discussion of the rationale behind the
model is held before the patient makes a decision. Participants can admit
themselves at will for a maximum of 7 days by contacting the ward
directly. There is no explicit limit on how often participants can self-
admit. If both designated beds are already occupied by another patient
in the program, a waiting list is established.
The self-admission contract is valid for 1 year, with the possibility
of renewal annually. Importantly, self-admission is constructed as an
add-on treatment option and regular admission is still available for
participants if necessary.
2.2 | Study design and participants
In this cohort study, the outcomes at 12-month follow-up for partici-
pants in the self-admission program were analyzed alongside those of
two comparison groups. All 34 patients who were offered to partake
in the self-admission program at SCÄ between August 2014 and Feb-
ruary 2019 were invited to participate in the study. None declined to
have their healthcare utilization data collected, although a few did not
actively participate in completing baseline or follow-up question-
naires. Therefore, n varies somewhat for different outcome parame-
ters presented in Section 3. A few participants ended up staying in
the program <6 months (due to ending the treatment contact at SCÄ
because of remission, suicide attempt, or substance use) and were not
assessed at 12-month follow-up. Therefore, a total of 29 participants
constituted the participant cohort. One patient committed suicide
after 11 months in the program; her data up until that point were
included in the analyses. For the remaining 28 participants, data on
their first 12 months in the program were included. All participants
had an AN diagnosis as defined in the International Classification of
Diseases, 10th Revision (albeit in some cases partly in remission). Many,
but not all, fulfilled suggested criteria for SE-AN (Wonderlich
et al., 2020). An a priori estimation of statistical power using G*Power
3.1.9.2 based on the medium effect sizes seen in available Norwegian
data (Strand & von Hausswolff-Juhlin, 2015) and assuming a two-
sided null hypothesis of no effect suggested that power above 80%
would be achieved at a level of 26 participants.
A larger comparison group was established using the national eating
disorder quality register Stepwise, which has been found to be valid and
reliable (Birgegård, Björck, & Clinton, 2010; Emilsson, Lindahl, Köster,
Lambe, & Ludvigsson, 2015). During the years covered by this study,
data on patients in treatment at specialist eating disorder services
throughout Sweden were routinely entered into Stepwise, and individ-
uals from this source thus represent a “treatment as usual” population in
comparison to the participants who received eating disorder specialist
treatment with self-admission as an add-on tool. By definition, the indi-
viduals identified in the Stepwise register were enrolled in eating disor-
der specialist treatment and had access to inpatient treatment, although
the exact access may vary somewhat according to geography. Partici-
pants and the comparison group were matched based on age, duration
of illness, and BMI. We also attempted to use gender as a matching
parameter, but this was not possible due to a low number of men in
corresponding age spans. Eating disorder diagnosis was not used as a
matching parameter; it was assumed that since all participants had an
AN diagnosis (albeit in some cases in partial remission), using BMI as
matching parameter would result in an adequate diagnostic match. Ethi-
cal permits allowed for a 1:10 ratio of participants to comparison group;
however, due to a scarcity of individuals with matching severity of illness
in the register, a 1:4 ratio was achieved. However, for two participants it
was only possible to identify two and three adequate matches, respec-
tively. Thus, the comparison group comprised 113 individuals in total
who were included in the Stepwise register between 2013 and 2017.
As described in Section 3, although a satisfactory baseline match
was achieved in terms of age, gender, duration of illness, and BMI, the
two groups differed in terms of previous healthcare utilization—this
was largely due to the fact that a majority of individuals in the com-
parison group had no days in inpatient treatment in the 12 months
prior to inclusion in the Stepwise database. Therefore, the larger com-
parison group is referred to as the “low-utilization comparison group.”
Separate sensitivity analyses were performed whereby only those
individuals in the larger comparison group who had received inpatient
treatment in the 12 months before baseline were included. In the fol-
lowing, this group, comprising 27 individuals who were a somewhat
better match in terms of days spent in inpatient treatment, is referred
to as the “moderate-utilization comparison group.”
Additional data on comorbidity were retrieved from the National
Patient Register (see outcome measures in section 2.3). Data on the
occurrence of binge-purge behaviors as part of a patient's eating dis-
order were retrieved from the Stepwise register.
2.3 | Outcome measures
For analyzing healthcare utilization, this study makes use of the high-
quality nationwide registers maintained by the Swedish government,
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which covers the Swedish population in its entirety (Ludvigsson
et al., 2016). Specifically, data on the number of days in and frequency
of inpatient treatment, number of days in involuntary inpatient treat-
ment, and number of outpatient visits during 12 months prior to and
after baseline were retrieved from the National Patient Register, kept
by the Swedish National Board of Health and Welfare. Specific data
on participants' self-admission episodes were retrieved from patient
records.
To evaluate impact on eating disorder morbidity, changes in BMI,
Eating Disorders Examination Questionnaire (EDE-Q) 6.0 scores, and
Clinical Impairment Assessment Questionnaire (CIA) 3.0 scores
between baseline and 12-month follow-up were assessed. EDE-Q is a
self-report instrument consisting of 28 items and 3 additional ques-
tions that measures features of psychopathology related to an eating
disorder, generating a global score and scores on four subscales:
restraint, eating concern, shape concern, and weight concern (Fairburn
& Beglin, 2008, 1994). CIA is a 16-item self-report instrument mea-
suring the severity of psychosocial impairment due to an eating disor-
der (Bohn et al., 2008; Bohn & Fairburn, 2008). EDE-Q and CIA have
both been translated and validated for use in a Swedish setting
(Welch, Birgegård, Parling, & Ghaderi, 2011). Moreover, the Global
Assessment of Functioning (GAF) scale included in the fourth edition
of the Diagnostic and Statistical Manual of Mental Disorders (American
Psychiatric Association, 1994) was used. Unfortunately, the number
of individuals in the comparison groups with available follow-up data
on eating disorder morbidity and GAF were too small to allow for
meaningful statistical analyses.
To evaluate impact on participants' HRQoL, the generic prefer-
ence-based self-report instruments EQ-5D-3L (from here on referred
to as EQ-5D) and the Short Form 36 (SF-36) were used, both of which
are widely used measures of general health in clinical studies through-
out the world. EQ-5D assesses five attributes of health—mobility,
self-care, usual activities, pain/discomfort, and anxiety/depression—
on three severity levels (Drummond, Sculpher, Claxton, Stoddart, &
Torrance, 2015). The instrument also contains a visual analog scale
(VAS) where respondents rate their overall health state on a 0–100
scale. The respondent answers on EQ-5D can be transformed into a
single-index health status value, which has been developed using a
time trade-off approach (Drummond et al., 2015). In the present
study, country-specific experience value sets for Sweden were used
(Burström et al., 2014). SF-36 consists of 36 items generating eight
dimension scores and two summary scores for physical and mental
health. These scores can then be transformed into a single-index mea-
sure known as SF-6D, which has been developed based on standard
gamble measurements (Drummond et al., 2015). Since no country-
specific SF-6D preference value set is available for Sweden, utility
scores developed in the United Kingdom and licensed by the Univer-
sity of Sheffield were used (Brazier, Roberts, & Deverill, 2002). Partici-
pants' HRQoL was assessed at baseline and at 12 months follow-up;
however, it was not possible to obtain HRQoL data for the compari-
son groups.
Data on sick leave for participants and comparison groups were
retrieved from the Longitudinal Integrated Database for Health
Insurance and Labor Market Studies (LISA) at Statistics Sweden, which
comprise aggregated data from the Swedish Social Insurance Agency
(SIAS). All Swedish residents aged 16–64 years are covered by univer-
sal health insurance and receive economic support if their ability to
work is limited due to sickness, injury, or disability. Various forms of
benefits exist. For the present study, data on sick leave, sick leave for
rehabilitation, and disability leave (from here on collectively referred
to as “sick leave”) were collected. The first day of sick leave is not
compensated and the 13 days that follow are compensated by the
employer. After this, the benefits are paid for by SIAS. Therefore,
periods of sick leave <14 days are not registered in the database,
except for students and the unemployed. At the time of analysis, data
on sick leave up until 2017 were available in the LISA database. For a
small number of participants who were included after January 1,
2018, additional sick leave data were obtained from patient records.
2.4 | Statistical analysis
For all statistical analyses, IBM® SPSS® Statistics 26 was used. For
eating disorder morbidity and HRQoL where data before and after
inclusion were compared, paired t-tests were performed. For data on
healthcare utilization during the 12 months before and after inclusion,
the differences between pairs were generally not normally distributed.
Thus, for these data, we performed Wilcoxon signed-rank tests.
Regarding sick leave, aggregated data are available in the LISA
database at full-year level only. Thus, in the assessment of changes in
sick leave, data were analyzed over three time-points: the full year
before inclusion, the full baseline (inclusion) year, and the full year
after inclusion. Mauchly's sphericity test showed that sphericity could
be assumed for participant and moderate-utilization comparison
group data but not for the low-utilization comparison group data. A
repeated measures analysis of variance (with Greenhouse–Geisser
correction for the low-utilization comparison group) was performed.
In all analyses, an α level of <.05 was considered statistically sig-
nificant. Bonferroni corrections were also applied to compensate for
multiple comparisons. For statistically significant paired t-tests,
Cohen's d effect sizes were calculated, considering values around 0.2
as small, 0.5 as medium, and 0.8 as large. Calculating effect sizes for
nonparametric data is not a straightforward task. For statistically sig-
nificant Wilcoxon signed-rank tests, we chose to use the matched-pair
rank-biserial correlation suggested by Kerby (2014) in assessing effect
sizes.
2.5 | Ethics, pre-registration, and adherence to
reporting guidelines
All procedures were conducted in accordance with the Helsinki decla-
ration. The study was approved by the Regional Ethical Review Board
in Stockholm, Sweden (Nos. 2014/1586-31, 2015/1537-32, 2018/
1184-32, and 2020-00831). Informed consent was obtained from all
participants prior to inclusion. The study protocol was pre-registered
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at ClinicalTrials.gov (ID: NCT02937259). Notably, the protocol was
later updated and aligned with other studies in the field to allow for
the use of matched comparison groups as described earlier. In
reporting our findings, we have adhered to the STROBE statement on
improving the quality of reporting of observational studies (von Elm
et al., 2007).
3 | RESULTS
Baseline characteristics of participants and the low- and moderate-uti-
lization comparison groups are provided in Table 1. As seen, although
a good match was achieved in terms of gender, age, duration of ill-
ness, and BMI, the three groups differed in terms of comorbidity;
most obviously, a personality disorder diagnosis was much more com-
mon in the moderate-utilization comparison group. Furthermore, both
comparison groups more often displayed binge-purge behaviors,
whereas participants in the self-admission program more often had an
ADHD/ADD or autism diagnosis.
Figure 1 illustrates participants' inpatient treatment utilization in
the 12 months prior to and after inclusion; here, a large increase in
admission frequency corresponded to a sharp decrease in the number
of days spent in hospital. Data on healthcare utilization across the
three groups are provided in Table 2. Overall, a significant reduction
in participants' utilization of inpatient treatment was seen, which
remained after Bonferroni correction. This corresponded to a mat-
ched-pairs rank-biserial correlation level of 0.73; i.e., a medium to
large effect size.
Data on eating disorder morbidity and GAF for participants are
provided in Table 3. Overall, a significant slight increase in BMI was
seen, corresponding to a Cohen's d of 0.45; i.e., a medium effect size.
However, this change was not significant after Bonferroni correction.
Moreover, a significant increase in GAF score was seen,
corresponding to a Cohen's d of 0.61; i.e., a medium effect size.
Data on changes in participants' HRQoL are presented in Table 4.
Here, no major changes in terms of the EQ-5D single-index value or
the SF-36 standard gamble health state variation were seen; it can be
noted that the participants scored fairly high at baseline on these
measures. An analysis of item-level distribution of EQ-5D data did not
reveal any major changes. In contrast, a significant increase in terms
of EQ VAS was seen, corresponding to a Cohen's d of 0.78; i.e., a large
effect size.
See Figure 2 for absolute numbers regarding the three time-point
longitudinal data on sick leave. There was an overall significant differ-
ence in the mean number of sick leave days between time points for
the low-utilization comparison group (F[1.836, 205.597] = 6.378,
p = .003) and for the moderate-utilization comparison group (F[2,
52] = 3.462, p = .039), but not for participants (F[2, 56] = 3.078,
p = .054). However, pairwise comparisons revealed that for partici-
pants, the increase in the mean number of sick leave days between
the year before inclusion and the baseline year was significant
(p = .012), whereas the decrease between the baseline year and the
year after inclusion was not (p = .090). Hence, there was a discrepant
pattern in the participant group vs. both comparison groups. All three
groups displayed an increase in days on sick leave between the year
before inclusion and the baseline year. However, the two comparison
groups displayed a further increase in sick leave days between the
baseline year and the year after inclusion, whereas the participant
group displayed a parallel decrease (even though it did not reach sta-
tistical significance).
TABLE 1 Baseline characteristics of participants and comparison groups
Participants Low-utilization comparison group Moderate-utilization comparison group
n 29 113 27
% women 93.2 98.2 96.3
Years of age 29.7 (10.6) 27.8 (10.4) 30.2 (12.3)
Duration of illness in years 13.4 (10.6) 11.7 (10.5) 14 (12.3)
BMI 15.8 (2.3) 16.5 (1.8) 15.8 (1.6)
EDE-Q global score 3.3 (1.2) 3.5 (1.4) 3.6 (1.7)
CIA score 30.0 (10.4) 31.1 (10.4) 34.3 (10.3)
% with binge-purge behaviors 10.3 39.8 25.9
% with affective disorder 55.2 30.1 44.4
% with anxiety disorder 41.4 31.0 51.9
% with OCD 13.8 8.8 14.8
% with personality disorder 6.9 9.7 25.9
% with ADHD/ADD 10.3 4.4 3.7
% with autism 6.9 1.8 3.7
Note: Values are means unless otherwise indicated. SDs are presented in parentheses wherever applicable.
Abbreviations: ADD, attention-deficit disorder; ADHD, attention-deficit/hyperactivity disorder; BMI, body-mass index; CIA, Clinical Impairment Assess-
ment Questionnaire; EDE-Q, Eating Disorder Examination Questionnaire; OCD, obsessive–compulsive disorder.
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F IGURE 1 Participants' utilization of
inpatient treatment in terms of number of
days spent in hospital and admission
frequency during the 12 months before
(left of middle baseline) and after (right of
middle baseline) inclusion [Color figure
can be viewed at wileyonlinelibrary.com]














pctl. % Change Z p
Participants (n = 29) Days in inpatient treatment 139.7 80.5 124.0 180.0 68.2 3.5 31.0 119.0 −51.1 −3.406a .001
Number of admissions 2.3 1.0 1.0 3.0 6.3 1.0 4.0 11.0 +171.7 −3.193b .001
Days in involuntary
inpatient treatment
10.3 0.0 0.0 0.0 9.4 0.0 0.0 0.0 −9.3 −0.105b .917
Number of outpatient visits 11.5 5.5 8.0 13.0 12.8 6.5 11.0 16.0 +11.7 −0.974b .330
Low-utilization
comparison
group (n = 113)
Days in inpatient treatment 17.0 0.0 0.0 0.0 22.9 0.0 0.0 2.5 +34.7 −1.128b .259
Number of admissions 0.5 0.0 0.0 0.0 0.7 0.0 0.0 1.0 +36.8 −1.607b .108
Days in involuntary
inpatient treatment
4.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 −28.0 −0.204a .838




Days in inpatient treatment 71.0 4.0 32.0 112.0 62.4 0.0 24.0 105.0 −12.1 −0.961a .336
Number of admissions 2.2 1.0 2.0 3.0 2.1 0.0 1.0 3.0 −6.7 −0.324a .746
Days in involuntary
inpatient treatment
18.4 0.0 0.0 0.0 6.1 0.0 0.0 0.0 −70.0 −1.014a .310
Number of outpatient visits 6.7 2.0 5.0 9.0 6.5 2.0 4.0 9.0 −2.8 −0.305a .761
aBased on positive ranks.
bBased on negative ranks (Pctl. = percentile).
TABLE 3 Changes in eating disorder
symptomatology and global assessment
of functioning among participants
Before After % Change p n
BMI 15.8 (2.3) 16.7 (2.5) +6.1 .023 29
EDE-Q global score 3.2 (1.2) 2.9 (1.2) −8.1 .203 23
EDE-Q restraint 2.8 (1.7) 2.6 (1.7) −7.1 .492 23
EDE-Q eating concern 2.4 (1.1) 2.1 (1.0) −10.3 .308 23
EDE-Q weight concern 3.3 (1.3) 3.1 (1.4) −6.1 .411 23
EDE-Q shape concern 4.2 (1.3) 3.9 (1.4) −9.0 .095 23
CIA 30.0 (9.0) 27.5 (8.4) −8.3 .272 18
GAF 31.2 (11.0) 41.5 (16.7) +33.0 .007 24
Note: Values are means unless otherwise indicated. SDs are presented in parentheses wherever
applicable.
Abbreviations: BMI, body-mass index; CIA, Clinical Impairment Assessment Questionnaire; EDE-Q, Eating
Disorder Examination Questionnaire; GAF, Global Assessment of Functioning.
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4 | DISCUSSION
The present study reveals that participants in a self-admission pro-
gram for patients at a specialist eating disorder service displayed a
more than 50% reduction in time spent hospitalized at 12-month fol-
low-up, compared to small and statistically nonsignificant changes in
low- and moderate utilization comparison groups. In contrast, the
approach did not significantly affect participants' BMI or eating disor-
der morbidity. In terms of HRQoL, mixed results were seen with a
25% improvement on the overall EQ VAS, but no changes in more
specific measures. There were no significant effects on the time spent
in involuntary inpatient treatment or on the number of outpatient
visits between groups. For number of sick leave days, a beneficial pat-
tern was seen for the participant group; however, this did not reach
statistical significance.
Taken together, these findings indicate that whereas being
offered self-admission as a treatment tool helped participants prevent
deterioration and reduce their need for inpatient treatment, it did not
help them achieve symptom remission. Although we initially hypothe-
sized that self-admission would also have some positive impact on
eating disorder morbidity, the present findings are understandable
given that the brief nature of these admissions means that they do
not allow for complete weight restoration or the achievement of other
long-term goals (Strand et al., 2015). Instead, they primarily represent
“booster” opportunities or brief respites at times when the risk of
deterioration is high. Previous qualitative research shows that partici-
pants mostly use self-admission in order to prevent prolonged hospital
admission, boost healthy routines, and get a break from hardships in
everyday life, rather than in hopes of achieving full remission (Strand,
Bulik, et al., 2017). Considering that the targeted participant group
displayed a mean duration of illness of 13.4 years, self-admission cer-
tainly does not provide a quick fix or catch-all solution. As an illustra-
tion, although participants displayed improved functioning as
measured by GAF, on average these changes corresponded to moving
from “major impairment in several areas” (range 30–40) to “serious
impairment in social, occupational, or school functioning” (range 40–
50) (American Psychiatric Association, 1994) for all groups, indicating
serious remaining functional impairment.
Based on these findings, self-admission is perhaps best under-
stood within a recovery model framework. In this model, which stems
from the consumer-advocacy movement, a distinction between recov-
ery from and recovery in a disorder is made (Davidson & Roe, 2007).
Whereas recovery from a disorder emphasizes a traditional notion of
cure, the concept of recovery in a disorder implies that even though
patients may still fulfill diagnostic criteria for certain disorders, they
have access to tools that help them manage symptoms and lead a
more fulfilling life in spite of not being formally cured. It has been
suggested that the recovery model might have particular relevance for
individuals with longstanding AN (Dawson, Rhodes, & Touyz, 2014)
and there are numerous examples of treatment approaches incorpo-
rating aspects of the recovery model, harm reduction principles, and
so forth for this patient group (Kaplan & Miles, 2016; Molin, von
Hausswolff-Juhlin, Norring, Hagberg, & Gustafsson, 2016; Russell,
Mulvey, Bennett, Donnelly, & Frig, 2019; Wildes et al., 2016; Wil-
liams, Dobney, & Geller, 2010). However, others have highlighted that
improvement in SE-AN patients' HRQoL may still primarily rely on
symptom change and that clinicians should not precipitously abandon
weight gain and change in behavioral symptoms as treatment goals
(Bamford et al., 2015). Based on our findings, self-admission seems to
fit well within a recovery model framework of increased focus on
patient autonomy and empowerment. Participants with eating disor-
ders in self-admission programs are generally satisfied with the model
(Strand, Bulik, et al., 2017). This, however, is unsurprising given that
they are offered increased access to a scarce resource—hospitals
beds—in psychiatry (Strand & Sjöstrand, 2019). The present study
TABLE 4 Changes in participants' health-related quality of life
Before After % Change p n
EQ-5D single-index value 0.7682 (0.1328) 0.8024 (0.1528) +4.4 .084 23
EQ visual analog scale 44.8 (15.3) 56.2 (21.0) +25.6 .001 22
SF-36 standard gamble health state variation 0.614 (0.053) 0.639 (0.086) +4.2 .056 22
Note: Values are means unless otherwise indicated. SDs are presented in parentheses wherever applicable.
F IGURE 2 Changes in mean number of sick leave days over three
time-points for participants and comparison groups [Color figure can
be viewed at wileyonlinelibrary.com]
STRAND ET AL. 1691
offers the first concrete evidence that the self-admission model can
actually help participants with SE-AN achieve quantifiable goals such
as reducing their need for inpatient treatment, even if this does not
promote symptom remission. With this in mind, it is advisable for clini-
cians and patients to discuss reasonable expectations before entering
into the program, in order to instill a nuanced understanding of the
self-admission concept (Strand, Gustafsson, Bulik, & Hausswolff-
Juhlin, 2017). Importantly, self-admission is an add-on tool and should
not replace a focus on remission wherever appropriate.
Previous qualitative research has showed that participants highly
valued the “safety net” function of self-admission and that they
believed that the program helped them expand their scope of everyday
activities (Strand, Bulik, et al., 2017). Therefore, the very modest find-
ings in the present study regarding changes in HRQoL are surprising.
Here, a number of observations can be made. A marked improvement
was seen in terms of EQ VAS, whereas no significant improvement was
seen in the EQ-5D single-index value—notably, the scores on the latter
were already relatively high at baseline. This may reflect a failure of the
main five-item part of EQ-5D to adequately capture everyday obstacles
experienced in AN. For example, participants generally scored high on
items related to mobility and self-care—indeed, many of the partici-
pants engaged in excessive physical exercise as a part of their AN
symptomatology and considered themselves highly mobile. Further-
more, upon closer scrutiny participants' SF-36 data reveal that many of
those who scored low on items related to their own well-being also
answered that their health was no worse than that of other people they
know, inflating total scores. This could hypothetically reflect a limited
social network; not least, after prolonged treatment episodes some SE-
AN patients may mostly know others in similar situations. It was also
observed that many of those who answered that their subjective well-
being had improved also scored higher on items related to specific
everyday difficulties on follow-up. This may reflect an increased insight
into one's own problems over time (Gorse, Nordon, Rouillon, Pham-
Scottez, & Revah-Levy, 2013), whereas baseline answers may present a
more “glossy” picture colored by AN cognitions. As patients change,
the basis on which they appraise their HRQoL may also change, a phe-
nomenon known as response shift (Schwartz, Andresen, Nosek, &
Krahn, 2007). Issues such as these make the EQ-5D and SF-36 out-
comes somewhat difficult to interpret in the present context. The rela-
tively straightforward EQ VAS—on which our participants displayed a
25% improvement—may therefore be a better indicator, although the
use of VAS may also be associated with problems such as end-of-scale
and context bias (Drummond et al., 2015). Of course, analogous to the
GAF findings discussed earlier, a mean EQ VAS score of 56.1 (on a scale
from 0 to 100) at follow-up still indicates a remaining severe impair-
ment in HRQoL.
It is not possible to tell whether the beneficial pattern in number
of sick leave days seen in the participant group was due to improved
health status or if it was simply a result of the reduction in time spent
hospitalized. Importantly, since periods of sick leave <14 days are not
registered in the LISA database, one reason for the observed reduc-
tion could be that sick leave during the brief self-admission episodes
was not fully captured.
The findings reported here should be considered in the light of
several limitations. Implementing a service delivery intervention such
as self-admission may not be feasible in all countries, as healthcare
systems vary widely (Strand et al., 2015; Wonderlich et al., 2020). The
small number of participants limits statistical power and makes it diffi-
cult to assess effects of a lesser magnitude. Statistical power was cal-
culated based on the assumption that favorable changes of a
relatively large magnitude would be necessary in order to justify the
allocation of resources to the self-admission program. Even so, there
could have been clinically relevant changes in outcomes of a lesser
magnitude that were not fully captured. The highly naturalistic study
setting meant that a large proportion of eligible participants—i.e.,
known patients with severe AN in the Metropolitan Stockholm area—
were invited to participate in the program at some point. With around
2000 active treatment contacts and 1,200 new patients yearly, SCÄ is
a large-scale specialist service by international standards. Even so, the
number of eligible participants was ultimately limited. Indeed, it has
been noted that more collaborative efforts are necessary since many
services only have a small number of SE-AN patients on their caseload
(Wonderlich et al., 2020).
This also affected the chances of achieving an optimal match
between participants and comparison groups. A satisfactory baseline
match between groups was achieved regarding age, duration of ill-
ness, and BMI. However, further matching based on previous
healthcare utilization or sick leave was not feasible since it would have
required running cross-database queries involving different govern-
ment agencies. Further analysis showed that the participant group dis-
played a much higher level of previous healthcare utilization than the
comparison groups, even when comparison individuals with no inpa-
tient treatment during the previous 12 months were removed. This
can be expected given that the participants constitute a highly
selected group that has been included in the program precisely on the
grounds of having required inpatient treatment in the past. Even so,
baseline matching in terms of previous healthcare utilization was far
from optimal, which limits the comparability. The comparison group
results should therefore merely be seen as a reference indication of
how patterns in patients with longstanding eating disorders and low
or moderate utilization of inpatient treatment evolve over time. The
mean 71 days of inpatient treatment in the previous 12 months
observed in the moderate-utilization comparison group indicate that
these patients arguably spent relatively much time in hospital,
although not quite as much as the participant group.
There are several potential reasons for these discrepancies. Con-
sidering the differences in comorbidity, the higher need for hospitali-
zation among moderate utilizers could in fact be related to the
overrepresentation of personality disorders in this group. In contrast,
participants were more likely to suffer from restricting subtype AN
and more often had an ADHD/ADD or autism diagnosis—these char-
acteristics may coincide and imply a poorer treatment response over
time (Westwood & Tchanturia, 2017). Moreover, baseline BMI,
although moderately to severely low, was not in the extreme range (as
outlined in the fifth edition of the Diagnostic and Statistical Manual of
Mental Disorders) for any of the groups. Among participants, who had
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spent more time hospitalized in the previous 12 months, this could
imply that they had initially had an even lower BMI that had prompted
inpatient treatment in the first place and that their baseline BMI rep-
resented a relatively higher body weight after discharge. In contrast,
for the low-utilization comparison group in particular, baseline BMI
might have been more stable over time, since their status had obvi-
ously not prompted inpatient treatment in the previous 12 months
despite a longstanding severe illness.
Perhaps most importantly, even though the self-admission pro-
gram is in and by itself a novel and experimental approach to treat-
ment, it was not possible to conduct a formal experimental study of
the model. Due to the fact that the Stockholm County Council made a
decision early on to roll out self-admission on a broader scale even
though its effectiveness had not yet been trialed, it was not possible
to randomly allocate eligible patients to either active participation in
the program or a control condition—this would have meant that
patients were not offered treatment on equal terms, which is unac-
ceptable once a treatment tool is established as a standard option.
Thus, the intervention had to be evaluated using a cohort study
approach.
In future studies of similar programs, an alternative could be a so-
called stepped wedge cluster randomized trial approach—a study
design increasingly being used in the evaluation of service delivery
interventions (Hemming, Haines, Chilton, Girling, & Lilford, 2015). In a
stepped wedge trial, services (e.g., hospital wards) rather than individ-
ual patients are randomized to the sequential implementation of a
novel intervention over a specified time period until patients at all
sites have been exposed. Thus, every site eventually switches from
control status to exposure status but at various time points. A stepped
wedge design is explicitly recommended in situations where logistical
and political constraints exist, such as when stakeholders (e.g., man-
agers or politicians) wish to roll out a novel intervention on a broader
scale based partly on attentiveness to constituents who may not
accept that a government would randomly assign citizens to govern-
ment programs (Hemming et al., 2015).
4.1 | Conclusion
This is the first study to report the effects of self-admission as a tool
in the treatment of patients with AN on healthcare utilization, eating
disorder morbidity, HRQoL, and sick leave. Participants in the self-
admission program displayed a more than 50% reduction in time spent
hospitalized at 12-month follow-up, compared to small, nonsignificant
changes in comparison groups. In contrast, the approach did not affect
participants' BMI or eating disorder morbidity. In terms of HRQoL,
participants reported a 25% improvement on the overall VAS measure
but no changes on more specific measures. These findings indicate
that self-admission is a viable and helpful tool within a recovery model
framework, even though it does not lead to symptom remission. In its
proper context, self-admission could potentially transform healthcare
from crisis-driven to pre-emptive, and promote autonomy for severely
ill patients.
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